IP Library Granted Patent US 7,910,699
Granted Patent B2
US 7,910,699 · App. 11/921,905 · Granted Mar 22, 2011

Cysteine-depleted hydrophobin fusion proteins, their production and use thereof

Assignee: BASF SE
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,699
App. No.
11/921,905
Granted
Mar 22, 2011
Kind
B2
Abstract

Polypeptides of the general structural formula (I) X n —C 1 —X 1-50 —C 2 —X 0-5 —C 3 —X p —C 4 —X 1-100 —C 5 —X 1-50 —C 6 —X 0-5 —C 7 —X 1-50 —C 8 —X m   (I), production and use thereof.

Claims (12)

1. A polypeptide of the general structural formula (I)

X n —C 1 —X 1-50 —C 2 —X 0-5 —C 3 —X p —C 4 —X 1-100 —C 5 —X 1-50 —C 6 —X 0-5 —C 7 —X 1-50 —C 8 —X m   (I)

wherein each X is independently any of the 20 naturally occurring amino acids, n and m independently are numbers from 0 to 500, p is a number from 1 to 250, C is cysteine, alanine, serine, glycine, methionine or threonine wherein at least four residues designated as C are cysteine, at least one of the peptide sequences abbreviated as X n or X m or X p is a peptide sequence of at least 20 amino acids that is not naturally linked to a hydrophobin and X n or X m comprises a polypeptide sequence selected from the group consisting of SEQ ID NOs: 16 and 18, and wherein the polypeptide changes the contact angle of a drop of water on a glass surface by at least 20° after coating the glass surface with the polypeptide.

2. The polypeptide of claim 1 wherein the structural formula (I) comprises a Class I hydrophobin.

3. The polypeptide of claim 1 wherein the structural formula (I) comprises a hydrophobin selected from the group consisting of dewA, rodA, sc3, hypA, hypB, basf1, and basf2.

4. The polypeptide of claim 1 wherein the structural formula (I) comprises a sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, and 14.

5. The polypeptide of claim 1 wherein X n or X m or X p is a (His) 4-10 sequence.

6. The polypeptide of claim 1 wherein the structural formula (I) comprises polypeptides selected from the group consisting of SEQ ID NOs: 20, 22, and 24.

7. A nucleic acid encoding the polypeptide of claim 1 .

8. A method of producing a polypeptide by expressing the nucleic acid of claim 7 in a host organism and isolating the polypeptide.

9. The method of claim 8 wherein the host organism is E. coli.

10. A method for coating a surface with a polypeptide, the method comprising coating the surface with the polypeptide of claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Oct 19, 2010
From: BASF AKTIENGESELLSCHAFT
To: BASF SE
Reel/Frame 025159/0017 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2007
From: SUBKOWSKI, THOMAS; KAROS, MARVIN; LEMAIRE, HANS-GEORG; BARG, HEIKO; BOLLSCHWEILER, CLAUS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 020267/0716 →
Priority Claims (1)
DE 10 2005 027 139 · Jun 10, 2005 · national
Continuity (1)
Related Publication 20090136996A1 · May 28, 2009